EchoGo® Heart Failure vs cvi42 Auto Imaging
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent rather than direct competitors, as they focus on different imaging modalities and specific diagnostic applications. EchoGo® Heart Failure is specialized for rapid HFpEF detection using echocardiograms, ideal for quick diagnostic support. In contrast, cvi42 Auto Imaging provides comprehensive, multi-modality analysis of cardiac MR and CT images for a broader range of cardiovascular conditions, including detailed plaque assessment.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure by Ultromics analyzes routine echocardiograms to detect HFpEF. In contrast, cvi42 Auto Imaging by Circle Cardiovascular Imaging performs comprehensive analysis of cardiovascular MR and CT images.
EchoGou00ae Heart Failure is specifically designed for the detection of heart failure with preserved ejection fraction (HFpEF). cvi42 Auto Imaging offers a broader range of analyses, including cardiac MR (function, flow, tissue characterization, strain) and cardiac CT (calcium scoring, coronary arteries, plaque assessment), as well as vascular CT analysis.
EchoGou00ae Heart Failure delivers insights for HFpEF detection within 20 minutes. The information provided for cvi42 Auto Imaging does not specify a turnaround time for its comprehensive analyses.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is also covered in the hospital inpatient setting under DRG payment methodology. For cvi42 Auto Imaging, pricing information requires direct contact, though a new Category I CPT code 75577 for AI-enabled quantitative coronary plaque analysis, effective January 1, 2026, offers reliable revenue streams for cvi42 users, with Medicare and major insurers providing coverage.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. cvi42 Auto Imaging focuses on AI-enabled automated contouring and quantitative analysis, with its AI/ML performance validation showing high accuracy for CMR Function series classification (97%-100%) and calcium analysis (86%-99%).
EchoGou00ae Heart Failure is designed for seamless integration with existing workflows and IT stacks, utilizing DICOM for report delivery to PACS and offering HL7 messaging or API for flexibility. cvi42 Auto Imaging emphasizes streamlined clinical workflows, vendor-neutral compatibility, and simplified reporting with infographics and CAD-RADS classification, and integrates into existing CT workflows.